
CORD-19:c654596857bce9cdd64ffc51842048643107348c / 384118-384538
Annnotations
CORD-19-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T3289 | 0-420 | Sentence | denotes | In a multivariate analysis, the concurrent introduction of novel PI(s) (32 p) and/or different NA(s) (19 p) acted favorably until the 9th month of follow-up (P B/0.04), while genotypic mutations conferring NNRTI cross-resistance, usually associated with a broad resistance profile, predicted failure in all p (P B/0.001), and the response did not vary according to duration and type of prior therapy, and selected NNRTI. |
T40822 | 0-420 | Sentence | denotes | In a multivariate analysis, the concurrent introduction of novel PI(s) (32 p) and/or different NA(s) (19 p) acted favorably until the 9th month of follow-up (P B/0.04), while genotypic mutations conferring NNRTI cross-resistance, usually associated with a broad resistance profile, predicted failure in all p (P B/0.001), and the response did not vary according to duration and type of prior therapy, and selected NNRTI. |
Epistemic_Statements
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T496 | 0-420 | Epistemic_statement | denotes | In a multivariate analysis, the concurrent introduction of novel PI(s) (32 p) and/or different NA(s) (19 p) acted favorably until the 9th month of follow-up (P B/0.04), while genotypic mutations conferring NNRTI cross-resistance, usually associated with a broad resistance profile, predicted failure in all p (P B/0.001), and the response did not vary according to duration and type of prior therapy, and selected NNRTI. |
CORD-19_Custom_license_subset
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T289 | 0-420 | Sentence | denotes | In a multivariate analysis, the concurrent introduction of novel PI(s) (32 p) and/or different NA(s) (19 p) acted favorably until the 9th month of follow-up (P B/0.04), while genotypic mutations conferring NNRTI cross-resistance, usually associated with a broad resistance profile, predicted failure in all p (P B/0.001), and the response did not vary according to duration and type of prior therapy, and selected NNRTI. |